Jeffrey R. Balser's most recent trade in CVS Health Corp was a trade of 2,375 Common Stock done at an average price of $57.1 . Disclosure was reported to the exchange on Nov. 21, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
CVS Health Corp | Jeffrey R. Balser | Director | Grant, award, or other acquisition of securities at price $ 57.10 per share. | 21 Nov 2024 | 2,375 | 9,652 (0%) | 0% | 57.1 | 135,613 | Common Stock |
CVS Health Corp | Jeffrey R. Balser | Director | Grant, award, or other acquisition of securities at price $ 57.52 per share. | 16 May 2024 | 2,184 | 7,277 (0%) | 0% | 57.5 | 125,624 | Common Stock |
CVS Health Corp | Jeffrey R. Balser | Director | Grant, award, or other acquisition of securities at price $ 69.13 per share. | 15 Nov 2023 | 1,817 | 5,093 (0%) | 0% | 69.1 | 125,609 | Common Stock |
CVS Health Corp | Jeffrey R. Balser | Director | Grant, award, or other acquisition of securities at price $ 69.31 per share. | 18 May 2023 | 1,329 | 3,276 (0%) | 0% | 69.3 | 92,113 | Common Stock |
CVS Health Corp | Jeffrey R. Balser | Director | Grant, award, or other acquisition of securities at price $ 94.93 per share. | 17 Nov 2022 | 1,323 | 1,947 (0%) | 0% | 94.9 | 125,592 | Common Stock |
CVS Health Corp | Jeffrey R. Balser | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Sep 2022 | 406 | 624 (0%) | 0% | 0 | Common Stock |